News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

German Biotech Company sphingotec Expands Into The U.S.



9/3/2014 8:59:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--sphingotec GmbH (www.sphingotec.de/en/) announced today that it has established its U.S. headquarters in Cambridge, Massachusetts. The Germany-based biotechnology company develops tests to detect individual risk factors for cancer, cardiovascular conditions and kidney disease. Its expansion into the U.S. will enable sphingotec to more rapidly meet growing market demand.

Commercial activities in the U.S. will be led by Karla M. Gonye, who will serve as president of the U.S. subsidiary. Gonye’s experience includes more than 20 years in the biotech, pharmaceutical and diagnostic industries. Most recently, Gonye led worldwide marketing and market development activities for BG Medicine.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES